Literature DB >> 12174371

Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.

Jia-Yin Yang1, Hua-You Luo, Qi-Yuan Lin, Zi-Ming Liu, Lu-Nan Yan, Ping Lin, Jie Zhang, Shong Lei.   

Abstract

AIM: To investigate the correlation between subcellular daunorubicin distribution and the multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
METHODS: The multidrug resistant cell line SMMC-7721/R, a human hepatocellular carcinoma cell line, was established. Antisense oligonucleotides (AS-ODN) were used to obtain different multidrug resistance phenotypes by inhibiting the expression of mdr1 gene and/or multidrug resistance-related protein gene(mrp) using Lipofectamine as delivery agent. Expression of mdr1 and mrp genes was evaluated by RT-PCR and Western blotting. Intracellular daunorubicin (DNR) concentration was measured by flow cytometry. Subcellular DNR distribution was analyzed by confocal laser scanning microscopy. Adriamycin (ADM) and DNR sensitivity was examined by MTT method.
RESULTS: Low level expression of mdr1 and mrp mRNAs and no expression of P-Glycoprotein(P-gp) and multidrug resistance-related protein (P(190)) were detected in parental sensitive cells SMMC-7721/S, but over-expression of these two genes was observed in drug-resistant cell SMMC-7721/R. The expression of mdr1 and mrp genes in SMMC-7721/R cells was down-regulated to the level in the SMMC-7721/S cells by AS-ODN. Intracellular DNR concentration in SMMC-7721/S cells was 10 times higher than that in SMMC-7721/R cells. In SMMC7721/S cells intracellular DNR distributed evenly in the nucleus and cytoplasm, while in SMMC-7721/R cells DNR distributed in a punctate pattern in the cytoplasm and was reduced in the nucleus. DNR concentration in SMMC-7721/R cells co-transfected with AS-ODNs targeting to mdr1 and mrp mRNAs recovered to 25 percent of that in SMMC7721/Scells. Intracellular DNR distribution pattern in drug-resistant cells treated by AS-ODN was similar to drug-sensitive cell, and the cells resistance index (RI) to DNR and ADM decreased at most from 88.0 and 116.0 to 4.0 and 2.3, respectively. Co-Transfection of two AS-ODNs showed a stronger synergistic effect than separate transfection.
CONCLUSIONS: P-gp and P(190) are two members mediating MDR in cell line SMMC7721/R. Intracellular drug concentration increase and subcellular distribution change are two important factors in multidrug resistance (MDR) formation. The second factor, drugs transport by P-gp and P(190) from cell nucleus to organell in cytoplasm, may play a more important role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174371      PMCID: PMC4656313          DOI: 10.3748/wjg.v8.i4.644

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

1.  Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs.

Authors:  Bing Xiao; Yong-Quan Shi; Yan-Qiu Zhao; Han You; Zuo-You Wang; Xian-Ling Liu; Fang Yin; Tai-Dong Qiao; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.

Authors:  X W Wang; J H Yuan; R G Zhang; L X Guo; Y Xie; H Xie
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.

Authors:  Q H Nie; Y Q Cheng; Y M Xie; Y X Zhou; Y Z Cao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

5.  Reversal of anticancer multidrug resistance by the ardeemins.

Authors:  T C Chou; K M Depew; Y H Zheng; M L Safer; D Chan; B Helfrich; D Zatorska; A Zatorski; W Bornmann; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.

Authors:  S Motomura; T Motoji; M Takanashi; Y H Wang; H Shiozaki; I Sugawara; E Aikawa; A Tomida; T Tsuruo; N Kanda; H Mizoguchi
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

Review 7.  Transplatin-modified oligonucleotides as modulators of gene expression.

Authors:  M Giraud-Panis; M Leng
Journal:  Pharmacol Ther       Date:  2000-03       Impact factor: 12.310

8.  Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.

Authors:  J P van Brussel; G J van Steenbrugge; J C Romijn; F H Schröder; G H Mickisch
Journal:  Eur J Cancer       Date:  1999-04       Impact factor: 9.162

9.  Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease.

Authors:  Wei-Xing Chen; You-Ming Li; Chao-Hui Yu; Wei-Min Cai; Min Zheng; Feng Chen
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

10.  Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Authors:  C P Leith; K J Kopecky; I M Chen; L Eijdems; M L Slovak; T S McConnell; D R Head; J Weick; M R Grever; F R Appelbaum; C L Willman
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

View more
  1 in total

1.  Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.

Authors:  Shao-Shan Wang; Ti Zhang; Xi-Lu Wang; Li Hong; Qing-Hui Qi
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.